Satoru Sasaki
About
In The Last Decade
Satoru Sasaki
66 papers receiving 997 citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Surgery 407
- Pulmonary and Respiratory Medicine 335
- Molecular Biology 297
- Cancer Research 231
- Oncology 164
Countries citing papers authored by Satoru Sasaki
This map shows the geographic impact of Satoru Sasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Sasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Sasaki more than expected).
Fields of papers citing papers by Satoru Sasaki
This network shows the impact of papers produced by Satoru Sasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Sasaki. The network helps show where Satoru Sasaki may publish in the future.
Co-authorship network of co-authors of Satoru Sasaki
This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Sasaki. A scholar is included among the top collaborators of Satoru Sasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Sasaki. Satoru Sasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 3 | |
| 7 | 6 | |
| 8 | The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells breakdown → | 311 |
| 9 | 14 | |
| 10 | 1 | |
| 11 | 9 | |
| 12 | A Clinical Study of Sclerotherapy for Venous Malformation of an Upper Extremity | 0 |
| 13 | 0 | |
| 14 | 17 | |
| 15 | 26 | |
| 16 | 10 | |
| 17 | 47 | |
| 18 | 8 | |
| 19 | 7 | |
| 20 | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.